BBSRC New Investigator Award given to Surrey academic for research into genes and the body clock

The grant, which will enable the employment of a full-time postdoctorate researcher, will specifically allow Dr Archer to study in more depth the two different variants of the PER3 polymorphism that he has already shown to be associated with extreme morning preference and delayed sleep phase syndrome.

More recently, Dr Archer and colleagues at the Surrey Sleep Research Centre, have studied people with the PER3 polymorphism in controlled sleep labs and found that this polymorphism also links strongly with the control and maintenance sleep.

The research will provide the models that will allow us to investigate further the molecular mechanisms of PER3 regulation of sleep and circadian biology.

Media Contact

Stuart Miller alfa

More Information:

http://www.surrey.ac.uk

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Making diamonds at ambient pressure

Scientists develop novel liquid metal alloy system to synthesize diamond under moderate conditions. Did you know that 99% of synthetic diamonds are currently produced using high-pressure and high-temperature (HPHT) methods?[2]…

Eruption of mega-magnetic star lights up nearby galaxy

Thanks to ESA satellites, an international team including UNIGE researchers has detected a giant eruption coming from a magnetar, an extremely magnetic neutron star. While ESA’s satellite INTEGRAL was observing…

Solving the riddle of the sphingolipids in coronary artery disease

Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new…

Partners & Sponsors